AM-Pharma
Phase 3AM-Pharma’s purpose is to save and improve the lives of patients confronted with severe medical conditions.
Founded
2002
Employees
51-200
Focus
Small Molecules
About
AM-Pharma’s purpose is to save and improve the lives of patients confronted with severe medical conditions.
Pipeline Snapshot
1313 drugs in pipeline, 1 in Phase 3
| Drug | Indication | Stage |
|---|---|---|
| Recombinant human alkaline phosphatase | Acute Kidney Injury Due to Sepsis | Phase 3 |
| Ilofotase alfa + Placebo | Open Heart Surgery | Phase 2 |
| recAP | Acute Kidney Injury | Phase 2 |
| Placebo + BIAP | Sepsis | Phase 2 |
| bovine intestinal alkaline phosphatase (BIAP) | Ulcerative Colitis | Phase 2 |
Funding History
7Total raised: $480M
Series C$116MLSPSep 15, 2020
Series D$100MForbion Capital PartnersJul 15, 2020
Series C$116MLSPJun 15, 2018
Series B$47MForbionJun 15, 2017
Company Info
TypePrivate
Founded2002
Employees51-200
LocationBunnik, Netherlands
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile